Also known as Aortic Valve Disorder
Aortic valve disease is encountered rarely on Symcat. We will add more content to this page if enough people like you show interest.
Within all the people who go to their doctor with aortic valve disease, 54% report having shortness of breath, 32% report having fatigue, and 32% report having sharp chest pain. The symptoms that are highly suggestive of aortic valve disease are lymphedema, although you may still have aortic valve disease without those symptoms.
Patients with aortic valve disease often receive radiographic imaging procedure, electrocardiogram, ultrasonography, echocardiography, lipid panel, other diagnostic procedures (interview; evaluation; consultation), diagnostic cardiac catheterization; coronary arteriography and cardiac stress tests .
The most commonly prescribed drugs for patients with aortic valve disease include furosemide, warfarin, carvedilol, diltiazem, digoxin, amiodarone, isosorbide, niacin, terazosin, potassium chloride, memantine (namenda), chondroitin-glucosamine and felodipine .
Furosemide | $4 (28 days) | |
Warfarin | $12 (28 days) | |
Carvedilol | $16 (28 days) | |
Diltiazem | $31 (28 days) | |
Digoxin | $6 (28 days) | |
Amiodarone | $18 (28 days) | |
Isosorbide | $12 (28 days) | |
Niacin | $105 (28 days) | |
Terazosin | $8 (28 days) | |
Potassium Chloride | $15 (28 days) | |
Memantine (Namenda) | $157 (28 days) | |
Chondroitin-Glucosamine | ||
Felodipine | $41 (28 days) |
Groups of people at highest risk for aortic valve disease include age 75+ years age 60-74 years.
< 1 years | 0.1x | |
1-4 years | 0.2x | |
5-14 years | 0.6x | |
15-29 years | 0.1x | |
30-44 years | 0.2x | |
45-59 years | 0.6x | |
60-74 years | 1.8x | |
75+ years | 5.1x |
Male | 1.1x | |
Female | 0.9x |
Black | 0.3x | |
Hispanic | 0.4x | |
White | 1.4x | |
Other | 0.6x |